Who we help
For the people accountable for a healthcare growth case.
Investors, operating partners and platform leadership use HAP at different moments, with the same need: a reliable view of the engine that produces new patients and what it means for value.
Healthcare private equity firms
For deal teams pricing a growth case.
Volume forecasts, de novo ramps and add-on lift are priced into the model long before anyone tests the engine that produces them. We give deal teams an evidence-based view of patient acquisition while there is still time to adjust price, structure or the decision to proceed.
What you need to know
- Whether the patient-growth assumptions in the model are supported by source data
- What a new patient really costs, and whether that cost holds as spend scales
- Which risks are deal-relevant and which are fixable after close
Operating partners and value-creation teams
For the people who own the plan after close.
The value-creation plan depends on patient growth that can be integrated, measured and managed across every company in the portfolio. We give operating partners a consistent way to secure the engine at close, sequence the integration and run growth on definitions the board trusts.
What you need to know
- A 100-day integration plan that protects patient volume
- One measurement standard across acquired practices and platforms
- An operating cadence that ties channel activity to board reporting
PE-backed healthcare platforms
For leadership teams scaling locations and add-ons.
Platform leaders are asked to grow patient volume across new markets and acquired practices while reporting results their investors can rely on. We help them fund growth where it returns, match demand to clinical capacity and build the evidence a future buyer will test.
What you need to know
- Budget allocated to measured return by market
- Demand matched to capacity before spend increases
- Exit-ready evidence of durable, transferable growth
Care settings
Healthcare businesses where patient acquisition drives the model.
Multi-location, consumer-facing care models where new-patient volume is a primary driver of revenue growth.
Fit
A good fit when…
- Patient volume growth is a material assumption in the investment case
- Reported marketing performance has not been verified against patient records
- A platform is adding practices and needs a repeatable integration standard
- The board wants patient growth reported on consistent, defensible definitions
- An exit is 12 to 24 months away and the growth story needs evidence
Start a conversation
Discuss an investment.
Whether you are evaluating a target, integrating an acquisition or planning an exit, a first conversation is a working session on the deal, not a presentation.
